{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T03:22:45Z","timestamp":1762917765099},"reference-count":14,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"13","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1097\/md.0000000000006271","type":"journal-article","created":{"date-parts":[[2017,3,28]],"date-time":"2017-03-28T16:58:06Z","timestamp":1490720286000},"page":"e6271","source":"Crossref","is-referenced-by-count":32,"title":["A life-threatening case of TAFRO syndrome with dramatic response to tocilizumab, rituximab, and pulse steroids"],"prefix":"10.1097","volume":"96","author":[{"given":"Fabio Freire","family":"Jos\u00e9","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucila Nassif","family":"Kerbauy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guilherme Fleury","family":"Perini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danielle Isadora","family":"Blumenschein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denise da Cunha","family":"Pasqualin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denise Maria Avancini Costa","family":"Malheiros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guilherme de Carvalho","family":"Campos Neto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabio Pires","family":"de Souza Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronaldo","family":"Piovesan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nelson","family":"Hamerschlak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-6-20210309","doi-asserted-by":"crossref","first-page":"2924","DOI":"10.1182\/blood-2013-12-545087","article-title":"HHV-8-negative, idiopathic multicentric Castleman disease: novel insights into biology, pathogenesis, and therapy","volume":"123","author":"Fajgenbaum","year":"2014","journal-title":"Blood"},{"key":"R2-6-20210309","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1046\/j.1440-1827.2001.01266.x","article-title":"HHV-8 infection status of AIDS-unrelated and AIDS-associated multicentric Castleman's disease","volume":"51","author":"Suda","year":"2001","journal-title":"Pathol Int"},{"key":"R3-6-20210309","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1056\/NEJM199403033300904","article-title":"Brief report: alleviation of systemic manifestations of Castleman's disease by monoclonal anti-interleukin-6 antibody","volume":"330","author":"Beck","year":"1994","journal-title":"N Engl J Med"},{"key":"R4-6-20210309","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/ajh.24242","article-title":"Clinicopathologic analysis of TAFRO syndrome demonstrates a distinct subtype of HHV-8-negative multicentric Castleman disease","volume":"91","author":"Iwaki","year":"2016","journal-title":"Am J Hematol"},{"key":"R5-6-20210309","doi-asserted-by":"crossref","first-page":"185","DOI":"10.2169\/internalmedicine.55.4710","article-title":"Successful treatment with cyclosporin A in tocilizumab-resistant TAFRO syndrome","volume":"55","author":"Yamaga","year":"2016","journal-title":"Intern Med"},{"key":"R6-6-20210309","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1620\/tjem.236.289","article-title":"Successful treatment of TAFRO syndrome, a variant of multicentric Castleman's disease, with cyclosporine A: possible pathogenetic contribution of interleukin-2","volume":"236","author":"Konishi","year":"2015","journal-title":"Tohoku J Exp Med"},{"key":"R7-6-20210309","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.bcmd.2015.06.013","article-title":"Castleman-Kojima disease (TAFRO syndrome) in a Caucasian patient: a rare case report and review of the literature","volume":"55","author":"Allegra","year":"2015","journal-title":"Blood Cells Mol Dis"},{"key":"R9-6-20210309","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/2162-3619-4-3","article-title":"Successful treatment of a Caucasian case of multifocal Castleman's disease with TAFRO syndrome with a pathophysiology targeted therapy: a case report","volume":"4","author":"Tedesco","year":"2015","journal-title":"Exp Hematol Oncol"},{"key":"R10-6-20210309","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3960\/jslrt.53.95","article-title":"Complete resolution of TAFRO syndrome (thrombocytopenia, anasarca, fever, reticulin fibrosis and organomegaly) after immunosuppressive therapies using corticosteroids and cyclosporin A: a case report","volume":"53","author":"Inoue","year":"2013","journal-title":"J Clin Exp Hematop"},{"key":"R11-6-20210309","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3960\/jslrt.53.79","article-title":"Japanese variant of multicentric castleman's disease associated with serositis and thrombocytopenia--a report of two cases: is TAFRO syndrome (Castleman- Kojima disease) a distinct clinicopathological entity?","volume":"53","author":"Masaki","year":"2013","journal-title":"J Clin Exp Hematop"},{"key":"R12-6-20210309","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3960\/jslrt.53.57","article-title":"Castleman-Kojima disease (TAFRO syndrome): a novel systemic inflammatory disease characterized by a constellation of symptoms, namely, thrombocytopenia, ascites (anasarca), microcytic anemia, myelofibrosis, renal dysfunction, and organomegaly: a status report and summary of Fukushima (6 June, 2012) and Nagoya meetings (22 September, 2012)","volume":"53","author":"Kawabata","year":"2013","journal-title":"J Clin Exp Hematop"},{"key":"R13-6-20210309","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1097\/00000478-199509000-00005","article-title":"Renal thrombotic microangiopathy associated with multicentric Castleman's disease. Report of two cases","volume":"19","author":"Lajoie","year":"1995","journal-title":"Am J Surg Pathol"},{"key":"R14-6-20210309","doi-asserted-by":"crossref","first-page":"165","DOI":"10.5414\/CN106491","article-title":"Successfully treated multicentric Castleman's disease with renal thrombotic microangiopathy using rituximab and corticosteroid","volume":"75","author":"Lee","year":"2011","journal-title":"Clin Nephrol"},{"key":"R15-6-20210309","doi-asserted-by":"crossref","first-page":"771","DOI":"10.7326\/0003-4819-119-8-199310150-00001","article-title":"Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome","volume":"119","author":"Casey","year":"1993","journal-title":"Ann Intern Med"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000006271","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:45:00Z","timestamp":1620960300000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201703310-00006"}},"subtitle":["The first case report in Latin America"],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":14,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000006271","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]}}}